Nadia El Menshawy (Nadia ElMenshawy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Patients Undergoing

Top Venues

Asian Pacific journal of cancer prevention : APJCP

Journal of immunoassay & immunochemistry

Mansoura University Oncology Centre

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mansoura University Oncology Centre May 10 2001

Egypt

Professor of Clinical Pathology :: Clinical Pathology

Publications

Nadia El Menshawy, Manal Ibrahim Fouda, Mohamed Mofreh, Heba Hisham El-Etriby, Manal O Elnenaei, Mohamed Eissa
Impact of CD34/CD309 expression in circulating endothelial progenitor cells on prognosis and response to bortezomib therapy in multiple myeloma. Journal of immunoassay & immunochemistry (2024)
Nadia El Menshawy, Manal Ibrahim Fouda, Mohamed Mofreh, Heba Hisham El-Etriby, Manal O Elnenaei, Mohamed Eissa
Impact of CD34/CD309 expression in circulating endothelial progenitor cells on prognosis and response to bortezomib therapy in multiple myeloma. Journal of immunoassay & immunochemistry 45 (5) (2024)
Nadia El Menshawy, Shaimaa El-Ashwah, Mohamed A Ebrahim, Metwally Ibrahem Mortada, Ahmed Ramez, Doaa M Attia
TERT Genotype Polymorphism: A Glance of Change Egyptian MDS Outcomes. Asian Pacific journal of cancer prevention : APJCP 22 (5) (2021)
Nadia El Menshawy, Ahmed B El Marghany, Mohamed M Sarhan, Doaa A Aladle
Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity. Asian Pacific journal of cancer prevention : APJCP 21 (10) (2020)